Molecular Health

08/11/2022

Join our webinar today to learn how to overcome IVDR challenges.

Register now: https://eu1.hubs.ly/H025X4p0

07/11/2022

Last chance to join our webinar to learn how to overcome IVDR challenges.

Register now: https://eu1.hubs.ly/H01YzL40

Tuesday, November 08, 2022 at 6:00 PM Central European Time. Regulatory changes from the new IVDR are in effect and have implications for how clinical laboratories operate. Learn how to overcome IVDR challenges. Register now for free!

03/11/2022

Innovation around tests, workflows, and services is vital to the continued competitiveness of any clinical laboratory. Meeting requirements of the new European In-Vitro Diagnostics Medical Device Regulation (EU) 2017/746 (IVDR) will go hand-in-hand with the implementation of new ideas. What are those requirements? How can you anticipate white space for new developments?

Join our Head of Quality Management on November 8th at 18:00 CET in an informative webinar about IVDR and ways to gain a competitive edge in precision medicine.

Register today: https://eu1.hubs.ly/H01YCfr0

27/10/2022

With new requirements coming into effect under the new European In-Vitro Diagnostics Medical Device Regulation (EU)2017/746 (IVDR), future-proofing your LDTs is likely on your mind. Let us help you assess the tests, workflows, and operations of your lab in light of IVDR.

Our Head of Quality Management Niels Bojunga oversaw the IVDR-certification of MH Guide, our evidence-based clinical decision support software. On November 8th at 18:00 CET, he shares lessons learned in a webinar you won’t want to miss.

Register today: https://eu1.hubs.ly/H01YCfl0

04/10/2022

Last chance to join our webinar to learn what everyone should know about comprehensive genomic profiling.
Register for free: https://eu1.hubs.ly/H01Mx_70

Wednesday, October 05, 2022 at 6:00 PM Central European Summer Time. The answer to optimal treatment decisions lies in your patients’ genes. Join our webinar on comprehensive genomic profiling to stay abreast of the evolving treatment landscape for cancers and enter the future with interdisciplina...

01/10/2022

EGFR, ALK, ROS1 and PD-L1 testing are nearly universally recommended by national guidelines in management of non-small cell lung cancer patients. And yet, patients still go untested (doi: 10.1016/j.lungcan.2020.10.012). Comprehensive genomic profiling (CGP) can help close that gap.
Join us for an informative webinar on the relevance and benefits of CGP, and how MH Guide distills the complexity of evaluating CGP results into evidence-based support to make treatment decisions.
We look forward to welcoming you! https://eu1.hubs.ly/H01MzCV0

28/09/2022

The answer to optimal treatment decisions lies in your patients’ genes. Join our on comprehensive genomic profiling to stay abreast of the evolving treatment landscape for cancers and enter the future with interdisciplinary therapy decision support.

Register for free: https://eu1.hubs.ly/H01Mx_00

21/09/2022

Comprehensive genomic profiling (CGP) combined with classification of detected genomic alterations according to ESCAT is a powerful tool to advance treatment decisions for cancer patients (https://eu1.hubs.ly/H01MzCz0). Join our educational webinar to learn how MH Guide automates the annotation of genomic alterations detected in CGP and highlights the most relevant therapy options or clinical trial eligibility for each evaluated case.

Register today: https://eu1.hubs.ly/H01MzyV0

16/09/2022

Molecular Health freut sich, das 16. Rhein-Main Symposium zur evidenzbasierten Therapie von Brustkrebs und gynäkologischen Tumoren als Sponsor und Aussteller zu unterstützen. Bringen Sie sich auf den neusten Stand und erhalten einen Überblick über wichtige Studienergebnisse des ESMO 2022.

Melden Sie sich jetzt noch kostenfrei an: https://eu1.hubs.ly/H01D_5G0

09/09/2022

SAVE THE DATE: 16. Rhein-Main Symposium
Wie jedes Jahr stellt das OncoNet Rhein-Main wichtige Studienergebnisse des ESMO 2022 rund um die evidenzbasierte Therapie von Brustkrebs und gynäkologischen Tumoren vor.

Molecular Health freut sich, die Veranstaltung am 17. September als Sponsor und Aussteller zu unterstützen. Zum Programm: https://eu1.hubs.ly/H01D_5s0